B. Zegels

A 2-Year Phase II Study with 1-Year of Follow-up of Risedronate (NE-58095) in Postmenopausal Osteoporosis

B. Clemmesen, Pernille Ravn, B. Zegels et al. · Osteoporosis International · 1997 · 74 citations

Bone Disease, Bone Health, Medicine +8

Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin

J.-Y. Reginster, D. Denis, Rita Deroisy et al. · Journal of Bone and Mineral Research · 1994 · 68 citations

Development and assessment of the Osteoporosis Index of Risk (OSIRIS) to facilitate selection of women for bone densitometry

W. B. Sedrine, T. Chevallier, B. Zegels et al. · Gynecological Endocrinology · 2002 · 36 citations

Bone Disease, Osteoporosis Index, Bone Health +14

Bone mineral density of the spine and the hip measured with dual energy X-ray absorptiometry: Normal range and fracture threshold for Western European (Belgian) postmenopausal females

J.-Y. Reginster, Catherine Janssen, Rita Deroisy et al. · Clinical Rheumatology · 1995 · 25 citations

Skeletal Trauma, Bone Imaging, Body Composition +11

Long-term performance in vitro and in vivo of dual-energy X-ray absorptiometry

Jean‐Yves Reginster, Rita Deroisy, B. Zegels et al. · Clinical Rheumatology · 1995 · 11 citations

X-ray Spectroscopy, Health Sciences, Medical Imaging +12